360iResearch Logo
Global Human Microbiome Market
Report Code: MRR-2AA0FD7 | Publishing Date: May 2020 | Number of Pages: 236
Global Human Microbiome Market | Market Research Report | Cumulative Impact of COVID-19

Market Dynamics:

The factors attributing to the growth of the market are increased focus on human microbiome therapy and human microbiome for drug development, early disease detection, and diagnosis. However, some factors such as limited expertise and lack of comprehensive research may hinder the market growth. The Human Microbiome Market is expected to showcase the opportunities such as increasing collaborations and research investments to create growth opportunities and development of human microbiome therapeutic products. In the near future market may face the possible challenges in the growth due to causal links between microbiota dysbiosis and disease. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Human Microbiome Market.

Market Segmentation & Coverage:

The research report categorizes the Human Microbiome Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Technology, the Human Microbiome Market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology.

On the basis of Therapeutic Area, the Human Microbiome Market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health.

On the basis of Product, the Human Microbiome Market is studied across Diagnostic Devices, Drugs, Foods, Medical Foods, Prebiotics, and Probiotics.

On the basis of Disease, the Human Microbiome Market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity.

On the basis of Application, the Human Microbiome Market is studied across Diagnostics and Therapeutics.

On the basis of Geography, the Human Microbiome Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The Human Microbiome Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market including DuPont, E.I. Du Pont De Nemours and Company, Enterome Bioscience, Merck & Co., Inc., Metabiomics Corporation, Microbiome Therapeutics, LLC, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synlogic Inc., Synthetic Biologics Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals, and Yakult Honsha Co., Ltd..

Scope of the Report:

AttributeDetails
Base Year for Estimation2019
Historical Period2017 - 2018
Estimation Period2020 - 2021
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Human Microbiome Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Human Microbiome Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Human Microbiome Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Human Microbiome Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Human Microbiome Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Human Microbiome Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Human Microbiome Market.
  • Evaluate the key vendors in the Human Microbiome Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
      1. 360iResearch Market Share Analysis
      2. 360iResearch Competitive Strategic Window
  3. Executive Summary
    1. Market Outlook
    2. Technology Outlook
    3. Therapeutic Area Outlook
    4. Product Outlook
    5. Disease Outlook
    6. Application Outlook
    7. Geography Outlook
    8. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Human Microbiome Market, By Geography
  5. Market Dynamics
    1. Introduction
      1. Drivers
        1. Increased focus on human microbiome therapy
        2. Human microbiome for drug development, early disease detection, and diagnosis
      2. Restraints
        1. Limited expertise and lack of comprehensive research
      3. Opportunities
        1. Increasing collaborations and research investments to create growth opportunities
        2. Development of human microbiome therapeutic products
      4. Challenges
        1. Causal links between microbiota dysbiosis and disease
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
      1. Regulatory Framework
      2. Patent & Funding
      3. Impact of Human Microbiome Therapeutics on Current Treatment Options
  7. Global Human Microbiome Market, By Technology
    1. Introduction
    2. 16s rRNA Sequencing
    3. Cell Culture Technology
    4. Computational Tools
    5. High-Throughput Technology
    6. Metagenomic Sequencing
    7. Omics Technology
  8. Global Human Microbiome Market, By Therapeutic Area
    1. Introduction
    2. Gastrointestinal Disorders
    3. Metabolic Disorders
    4. Skin Disorders
    5. Women’s Health
  9. Global Human Microbiome Market, By Product
    1. Introduction
    2. Diagnostic Devices
    3. Drugs
    4. Foods
    5. Medical Foods
    6. Prebiotics
    7. Probiotics
  10. Global Human Microbiome Market, By Disease
    1. Introduction
    2. Acute Diarrhea
    3. Autoimmune Disorders
    4. Cancer
    5. Diabetes
    6. Mental Disorders
    7. Obesity
  11. Global Human Microbiome Market, By Application
    1. Introduction
    2. Diagnostics
    3. Therapeutics
  12. Americas Human Microbiome Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  13. Asia-Pacific Human Microbiome Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  14. Europe, Middle East & Africa Human Microbiome Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  15. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
  16. Company Usability Profiles
    1. DuPont
    2. E.I. Du Pont De Nemours and Company
    3. Enterome Bioscience
    4. Merck & Co., Inc.
    5. Metabiomics Corporation
    6. Microbiome Therapeutics, LLC
    7. Osel, Inc.
    8. Second Genome, Inc.
    9. Seres Therapeutics
    10. Synlogic Inc.
    11. Synthetic Biologics Inc.
    12. Vedanta Biosciences, Inc.
    13. Vithera Pharmaceuticals
    14. Yakult Honsha Co., Ltd.
  17. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  32. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  33. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  37. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  38. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  39. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  40. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  41. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  42. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  43. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  44. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  45. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  46. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  47. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  48. CANADA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  49. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  50. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  51. CANADA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  52. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  53. MEXICO HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  54. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  55. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  56. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  57. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  58. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  59. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  60. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  61. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  62. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  63. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  64. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  65. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  66. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  67. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  68. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  69. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  70. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  71. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  72. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  73. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  74. CHINA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  75. CHINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  76. CHINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  77. CHINA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  78. CHINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  79. INDIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  80. INDIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  81. INDIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  82. INDIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  83. INDIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  84. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  85. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  86. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  87. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  88. INDONESIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  89. JAPAN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  90. JAPAN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  91. JAPAN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  92. JAPAN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  93. JAPAN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  94. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  95. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  96. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  97. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  98. MALAYSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  99. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  100. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  101. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  102. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  103. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  104. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  105. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  106. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  107. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  108. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  109. THAILAND HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  110. THAILAND HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  111. THAILAND HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  112. THAILAND HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  113. THAILAND HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  114. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  115. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  116. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  117. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  118. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  119. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  120. FRANCE HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  121. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  122. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  123. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  124. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  125. GERMANY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  126. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  127. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  128. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  129. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  130. ITALY HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  131. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  132. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  133. ITALY HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  134. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  135. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  136. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  137. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  138. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  139. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  140. QATAR HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  141. QATAR HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  142. QATAR HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  143. QATAR HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  144. QATAR HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  145. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  146. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  147. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  148. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  149. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  150. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  151. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  152. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  153. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  154. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  155. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  156. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  157. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  158. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  159. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  160. SPAIN HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  161. SPAIN HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  162. SPAIN HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  163. SPAIN HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  164. SPAIN HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  165. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  166. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  167. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  168. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  169. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  170. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  171. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2017-2025 (USD MILLION)
  172. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)
  173. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017-2025 (USD MILLION)
  174. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017-2025 (USD MILLION)
  175. GLOBAL HUMAN MICROBIOME MARKET: SCORES
  176. GLOBAL HUMAN MICROBIOME MARKET: BUSINESS STRATEGY
  177. GLOBAL HUMAN MICROBIOME MARKET: PRODUCT SATISFACTION
  178. GLOBAL HUMAN MICROBIOME MARKET: RANKING
  179. GLOBAL HUMAN MICROBIOME MARKET: MERGER & ACQUISITION
  180. GLOBAL HUMAN MICROBIOME MARKET: AGREEMENT, COLLABORATION & PARTNERSHIP
  181. GLOBAL HUMAN MICROBIOME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  182. GLOBAL HUMAN MICROBIOME MARKET: INVESTMENT & FUNDING
  183. GLOBAL HUMAN MICROBIOME MARKET: EDITION DETAILS
  184. GLOBAL HUMAN MICROBIOME MARKET: LICENSE DETAILS
  185. GLOBAL HUMAN MICROBIOME MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH PROCESS
  2. GLOBAL HUMAN MICROBIOME MARKET: RESEARCH EXECUTION
  3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
  6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (USD MILLION)
  8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  10. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN MICROBIOME MARKET, BY TYPE
  11. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2017-2025 (USD MILLION)
  12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  14. GLOBAL HUMAN MICROBIOME MARKET: MARKET DYNAMICS
  15. GLOBAL HUMAN MICROBIOME MARKET: PORTERS FIVE FORCES ANALYSIS
  16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2025 (USD MILLION)
  18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2019 VS 2025 (USD MILLION)
  19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2025 (USD MILLION)
  20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2019 VS 2025 (USD MILLION)
  21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2019 VS 2025 (USD MILLION)
  23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2025 (USD MILLION)
  24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
  25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025 (USD MILLION)
  26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  27. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  28. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  29. GLOBAL HUMAN MICROBIOME MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  1. DuPont
  2. E.I. Du Pont De Nemours and Company
  3. Enterome Bioscience
  4. Merck & Co., Inc.
  5. Metabiomics Corporation
  6. Microbiome Therapeutics, LLC
  7. Osel, Inc.
  8. Second Genome, Inc.
  9. Seres Therapeutics
  10. Synlogic Inc.
  11. Synthetic Biologics Inc.
  12. Vedanta Biosciences, Inc.
  13. Vithera Pharmaceuticals
  14. Yakult Honsha Co., Ltd.